Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Longitudinal assessment of ventricular volume trajectories in early-stage schizophrenia: evidence of both enlargement and shrinkage

P. Svancer, V. Capek, A. Skoch, M. Kopecek, K. Vochoskova, M. Fialova, P. Furstova, L. Jakob, E. Bakstein, M. Kolenic, J. Hlinka, P. Knytl, F. Spaniel

. 2024 ; 24 (1) : 309. [pub] 20240424

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc24014263

BACKGROUND: Lateral ventricular enlargement represents a canonical morphometric finding in chronic patients with schizophrenia; however, longitudinal studies elucidating complex dynamic trajectories of ventricular volume change during critical early disease stages are sparse. METHODS: We measured lateral ventricular volumes in 113 first-episode schizophrenia patients (FES) at baseline visit (11.7 months after illness onset, SD = 12.3) and 128 age- and sex-matched healthy controls (HC) using 3T MRI. MRI was then repeated in both FES and HC one year later. RESULTS: Compared to controls, ventricular enlargement was identified in 18.6% of patients with FES (14.1% annual ventricular volume (VV) increase; 95%CI: 5.4; 33.1). The ventricular expansion correlated with the severity of PANSS-negative symptoms at one-year follow-up (p = 0.0078). Nevertheless, 16.8% of FES showed an opposite pattern of statistically significant ventricular shrinkage during ≈ one-year follow-up (-9.5% annual VV decrease; 95%CI: -23.7; -2.4). There were no differences in sex, illness duration, age of onset, duration of untreated psychosis, body mass index, the incidence of Schneiderian symptoms, or cumulative antipsychotic dose among the patient groups exhibiting ventricular enlargement, shrinkage, or no change in VV. CONCLUSION: Both enlargement and ventricular shrinkage are equally present in the early stages of schizophrenia. The newly discovered early reduction of VV in a subgroup of patients emphasizes the need for further research to understand its mechanisms.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014263
003      
CZ-PrNML
005      
20240905133917.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12888-024-05749-5 $2 doi
035    __
$a (PubMed)38658884
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Svancer, Patrik $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Longitudinal assessment of ventricular volume trajectories in early-stage schizophrenia: evidence of both enlargement and shrinkage / $c P. Svancer, V. Capek, A. Skoch, M. Kopecek, K. Vochoskova, M. Fialova, P. Furstova, L. Jakob, E. Bakstein, M. Kolenic, J. Hlinka, P. Knytl, F. Spaniel
520    9_
$a BACKGROUND: Lateral ventricular enlargement represents a canonical morphometric finding in chronic patients with schizophrenia; however, longitudinal studies elucidating complex dynamic trajectories of ventricular volume change during critical early disease stages are sparse. METHODS: We measured lateral ventricular volumes in 113 first-episode schizophrenia patients (FES) at baseline visit (11.7 months after illness onset, SD = 12.3) and 128 age- and sex-matched healthy controls (HC) using 3T MRI. MRI was then repeated in both FES and HC one year later. RESULTS: Compared to controls, ventricular enlargement was identified in 18.6% of patients with FES (14.1% annual ventricular volume (VV) increase; 95%CI: 5.4; 33.1). The ventricular expansion correlated with the severity of PANSS-negative symptoms at one-year follow-up (p = 0.0078). Nevertheless, 16.8% of FES showed an opposite pattern of statistically significant ventricular shrinkage during ≈ one-year follow-up (-9.5% annual VV decrease; 95%CI: -23.7; -2.4). There were no differences in sex, illness duration, age of onset, duration of untreated psychosis, body mass index, the incidence of Schneiderian symptoms, or cumulative antipsychotic dose among the patient groups exhibiting ventricular enlargement, shrinkage, or no change in VV. CONCLUSION: Both enlargement and ventricular shrinkage are equally present in the early stages of schizophrenia. The newly discovered early reduction of VV in a subgroup of patients emphasizes the need for further research to understand its mechanisms.
650    _2
$a lidé $7 D006801
650    12
$a schizofrenie $x diagnostické zobrazování $x patologie $x patofyziologie $7 D012559
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a longitudinální studie $7 D008137
650    _2
$a dospělí $7 D000328
650    _2
$a mladý dospělý $7 D055815
650    _2
$a mozkové komory $x diagnostické zobrazování $x patologie $7 D002552
650    _2
$a ventriculi laterales $x diagnostické zobrazování $x patologie $7 D020547
650    _2
$a progrese nemoci $7 D018450
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a mladiství $7 D000293
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Capek, Vaclav $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic
700    1_
$a Skoch, Antonin $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic $u Department of Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kopecek, Miloslav $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Vochoskova, Kristyna $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Fialova, Marketa $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Furstova, Petra $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic
700    1_
$a Jakob, Lea $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Bakstein, Eduard $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic $u Department of Cybernetics, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic
700    1_
$a Kolenic, Marian $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hlinka, Jaroslav $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic
700    1_
$a Knytl, Pavel $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Spaniel, Filip $u National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic. filip.emailiel@nudz.cz $u Third Faculty of Medicine, Charles University, Prague, Czech Republic. filip.emailiel@nudz.cz
773    0_
$w MED00008204 $t BMC psychiatry $x 1471-244X $g Roč. 24, č. 1 (2024), s. 309
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38658884 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133911 $b ABA008
999    __
$a ok $b bmc $g 2143824 $s 1226129
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 24 $c 1 $d 309 $e 20240424 $i 1471-244X $m BMC psychiatry $n BMC Psychiatry $x MED00008204
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...